Three-dimensional (3D) human heart tissue can now be generated from stem cells that offers cheaper and faster method to create heart tissue for testing drugs and modelling disease.
The tissue also opens the door for a precision medicine approach to treating heart disease.
Advertisement
‘Heart cells created from skin-derived cells are challenging to make and work with, so creating large quantities can be difficult.’
Tweet it Now
"We have bioengineered micro-scale heart tissues with a method that can easily be reproduced, which will enable scientists in stem cell biology and the drug industry to study heart cells in their proper context," said Nathaniel Huebsch, postdoctoral fellow at San Francisco-based at the Gladstone Institutes.
"In turn, this will enhance our ability to discover treatments for heart disease," Huebsch added.
Creating heart cells from induced pluripotent stem cells (iPSCs) that are derived from a patient's skin cells is inadequate for drug testing because they do not properly predict how a drug will affect adult heart cells.
![Use of Stem Cells in Personalized Medicine]( "Use of Stem Cells in Personalized Medicine")
Stem cell therapy, a leading topic of interest among the budding scientists. These cells play a role in the development of personalized medicines for millions of cancer and heart patients.
Additionally, heart cells created from iPSCs are challenging to make and work with, so creating large quantities can be difficult.
The micro-heart muscle addresses these concerns. Forcing the cells to organise and stretch into 3D tissue helps spur development and coaxes them into resembling more mature cells that can better predict how a drug will affect adult heart cells.
The new method, requires a thousand-fold fewer cells to grow the tissue than other tissue engineering techniques.
Using fewer cells allows the scientists to do many more experiments with the same amount of resources.
"The beauty of this technique is that it is very easy and robust and still allows you to create three-dimensional miniature tissues that function like normal tissues," said senior author Bruce Conklin, senior investigator at Gladstone.
"We think that the micro-heart muscle will provide a superior resource for conducting research and developing therapies for heart disease," he noted.
Source: IANS
Creating heart cells from induced pluripotent stem cells (iPSCs) that are derived from a patient's skin cells is inadequate for drug testing because they do not properly predict how a drug will affect adult heart cells.
Use of Stem Cells in Personalized Medicine
Stem cell therapy, a leading topic of interest among the budding scientists. These cells play a role in the development of personalized medicines for millions of cancer and heart patients.
Advertisement
Additionally, heart cells created from iPSCs are challenging to make and work with, so creating large quantities can be difficult.
The micro-heart muscle addresses these concerns. Forcing the cells to organise and stretch into 3D tissue helps spur development and coaxes them into resembling more mature cells that can better predict how a drug will affect adult heart cells.
The new method, requires a thousand-fold fewer cells to grow the tissue than other tissue engineering techniques.
Using fewer cells allows the scientists to do many more experiments with the same amount of resources.
"The beauty of this technique is that it is very easy and robust and still allows you to create three-dimensional miniature tissues that function like normal tissues," said senior author Bruce Conklin, senior investigator at Gladstone.
"We think that the micro-heart muscle will provide a superior resource for conducting research and developing therapies for heart disease," he noted.
Source: IANS
Embryonic Stem Cells Could Help Study Pollution Effects on Human Health
Stem cell toxicology system proved to be very sensitive and reflective of the physiological toxic effects of the environmental pollutant Bisphenol A.
Advertisement
Advertisement
Recommended Reading
Latest Genetics & Stem Cells News
Can stem cell therapy cure fistula? Yes, treatment with stem cells has had a success rate when used in perianal fistulas due to Crohn's Disease.
In zebrafish models of SURF1 mitochondrial disease, scientists have discovered drugs to prevent neurological decompensation.
New study advances intravitreal gene therapy platform to develop safe and effective therapies for visual loss in Usher Syndrome, rare disorder.
The study experiments shed light on a rare example of how autism-associated mutation could altered nuclear dynamics.
A genotype-first approach to patient care involves selecting patients with specific genomic variants and then studying their traits and symptoms.
